ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,249, issued on Sept. 29, was assigned to SJP Biotec GmbH (Zurich, Switzerland).

"EIF4A-inhibiting compounds and methods related thereto" was invented by Justin T. Ernst (San Diego), Siegfried H. Reich (La Jolla, Calif.), Paul A. Sprengeler (Escondido, Calif.), Chinh Viet Tran (San Diego), Garrick Kenneth Packard (San Diego), Alan X. Xiang (Irvine, Calif.), Christian Nilewski (La Jolla, Calif.) and Theo Michels (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically a...